ClinicalTrials.Veeva

Menu

Individualized Prevention Strategy for High Risk Patients in Cardiovascular Disease: Prospective Cohort Study (Cardiovascular and Metabolic Disease Etiology Research Center - HIgh Risk Cohort) CMERC-HI

Yonsei University logo

Yonsei University

Status

Unknown

Conditions

High Risk Cardiovascular Disease Patients

Study type

Observational

Funder types

Other

Identifiers

NCT02003781
4-2013-0581

Details and patient eligibility

About

Set the prospective cohort (CMERC-HI) to study the known and novel etiologies and related factors for predicting clinical outcomes in Korean patients with high risk cardiovascular disease.

Enrollment

4,000 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • high risk hypertension patients a. eGFR > 60 with one of target organ damages b. eGFR <= 60
  • diabetes mellitus with microalbumin ration (AC ratio >= 30mg/g)
  • anuric ESRD patients on dialysis
  • the relatives of acute myocardial infarction patients under 55 years old (men)/ 65 years old (women)
  • atherosclerotic cardiovascular disease (abdominal aorta diameter ≥3 cm or ankle-brachial index <0.9, or carotid plaque or carotid intima-media thickness ≥0.9 mm, or asymptomatic old cerebrovascular accident, or >30% stenosis in at least one major coronary artery)
  • rheumatoid arthritis patients aged > 40 years on MTX and steroid therapy
  • atrial fibrillation patients with CHADS-VASc Score ≥ 1
  • kidney transplant recipient at > 3 months after transplantation

Exclusion criteria

  • acute myocardial infarction, acute coronary syndrome patients, symptomatic coronary artery disease or history of these diseases
  • symptomatic peripheral artery disease, heart failure and history of these diseases
  • desired life time under 6 months due to non-cardiovascular disease (e.g. cancer, sepsis)
  • women with pregnancy or on nursing
  • history of contrast allergy and related side effects
  • within the first three months after transplantation
  • acute renal allograft rejection

Trial design

4,000 participants in 1 patient group

cardiovascular disease
Description:
high risk cardiovascular disease patients and their relatives

Trial contacts and locations

1

Loading...

Central trial contact

Sungha Park, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems